ZA964193B - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- ZA964193B ZA964193B ZA964193A ZA964193A ZA964193B ZA 964193 B ZA964193 B ZA 964193B ZA 964193 A ZA964193 A ZA 964193A ZA 964193 A ZA964193 A ZA 964193A ZA 964193 B ZA964193 B ZA 964193B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Ophthalmology & Optometry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA954885 | 1995-06-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA964193B true ZA964193B (en) | 1996-12-04 |
Family
ID=25585147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA964193A ZA964193B (en) | 1995-06-13 | 1996-05-24 | Pharmaceutical composition |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU5774796A (en) |
WO (1) | WO1996041646A2 (en) |
ZA (1) | ZA964193B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATA156496A (en) * | 1996-09-03 | 1997-10-15 | Nycomed Austria Gmbh | PHARMACEUTICAL COMPOSITION |
TWI247609B (en) | 2001-01-23 | 2006-01-21 | Nihon Mediphysics Co Ltd | Agent for diagnosis of tissue proliferation activity or the treatment of proliferative disease |
MXPA04007328A (en) * | 2002-02-01 | 2005-07-05 | Shimoda Biotech Pty Ltd | Pharmaceutical composition. |
ES2287658T3 (en) * | 2004-03-10 | 2007-12-16 | Shimoda Biotech (Pty) Ltd | STABLE INJECTABLE COMPOSITIONS OF DICLOFENAC. |
KR20170123724A (en) | 2006-03-28 | 2017-11-08 | 자블린 파머슈티칼스 인코포레이티드 | Formulations of low dose diclofenac and beta-cyclodextrin |
EP2394641A1 (en) | 2010-05-30 | 2011-12-14 | Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi | Pharmaceutical formulations of lornoxicam |
UY38431A (en) * | 2018-10-31 | 2020-05-29 | Servier Lab | CYCLODEXTRIN-BASED FORMULATION OF A BCL-2 INHIBITOR |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3426011A (en) * | 1967-02-13 | 1969-02-04 | Corn Products Co | Cyclodextrins with anionic properties |
KR0166088B1 (en) * | 1990-01-23 | 1999-01-15 | . | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
US5376645A (en) * | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
CA2190598A1 (en) * | 1994-05-27 | 1995-12-07 | Lawrence John Penkler | Pharmaceutical composition |
ZA959469B (en) * | 1994-11-15 | 1996-05-15 | South African Druggists Ltd | Pharmaceutical composition |
-
1996
- 1996-05-23 AU AU57747/96A patent/AU5774796A/en not_active Abandoned
- 1996-05-23 WO PCT/GB1996/001236 patent/WO1996041646A2/en active Application Filing
- 1996-05-24 ZA ZA964193A patent/ZA964193B/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO1996041646A3 (en) | 1997-02-13 |
WO1996041646A2 (en) | 1996-12-27 |
AU5774796A (en) | 1997-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU9601698D0 (en) | Pharmaceutical composition | |
HUP9802999A3 (en) | Pharmaceutical composition containing n-propargyl-1-aminoindan | |
ZA967827B (en) | Pharmaceutical compositions | |
GB9519667D0 (en) | Pharmaceutical composition | |
ZA962214B (en) | Pharmaceutical composition | |
ZA963590B (en) | Pharmaceutical composition | |
EG24294A (en) | Pharmaceutical compositions | |
GB9506382D0 (en) | Pharmaceutical compositions | |
GB9513972D0 (en) | Pharmaceutical compositions | |
ZA96525B (en) | Novel pharmaceutical compositions | |
ZA9610426B (en) | Pharmaceutical composition | |
ZA961051B (en) | Pharmaceutical composition | |
ZA964193B (en) | Pharmaceutical composition | |
HUP9602822A2 (en) | Pharmaceutical composition | |
ZA963591B (en) | Pharmaceutical composition | |
ZA95736B (en) | Pharmaceutical composition | |
HUP9602732A3 (en) | Pharmaceutical composition comprising lanperisone | |
GB9514807D0 (en) | Pharmaceutical composition | |
ZA961735B (en) | Pharmaceutical composition | |
GB9507038D0 (en) | Pharmaceutical composition | |
GB9507037D0 (en) | Pharmaceutical composition | |
GB9515207D0 (en) | Pharmaceutical composition | |
GB9515208D0 (en) | Pharmaceutical composition | |
HU9903430D0 (en) | Pharmaceutical composition | |
ZA9510132B (en) | Pharmaceutical composition |